MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Neuropsychiatric Symptoms in Lewy Body Disease: Monoaminergic Activity and Resting State Networks

    L. Wright, D. Burn, J. Taylor, J. O'Brien, A. Yarnall, M. Firbank, A. Thomas, R. Lawson (Newcastle, United Kingdom)

    Objective: Investigating how neuropsychiatric symptoms (NPS)—depression, anxiety, and apathy—relate to functional connectivity between monoaminergic nuclei and the limbic network (LN), default mode network (DMN), and…
  • 2026 International Congress

    Huntington’s Disease Genetic Testing Practices in the Lower North Island of New Zealand

    D. Llewelyn, D. Bourke (Wellington, New Zealand)

    Objective: This audit reviewed Huntington’s Disease (HD) diagnostic and predictive testing in New Zealand’s lower North Island. Key objectives included evaluating the frequency of pre-test…
  • 2026 International Congress

    Predictors of Secondary Non-Response to Botulinum Neurotoxin Type-A in Cervical Dystonia: A Multi-Center Egyptian Study

    E. Abed (Cairo, Egypt)

    Objective: To investigate clinical and treatment predictors of SNR in Egyptian CD patients receiving BoNT-A therapy. Background: Secondary non-response (SNR) to botulinum neurotoxin type-A (BoNT-A)…
  • 2026 International Congress

    Benefit of Telemedicine Usage in Parkinson’s Disease Patients in Appalachia

    S. Rashid, D. Fletcher, J. Frey (Morgantown, USA)

    Objective: To assess telehealth patterns on socioeconomic and geographic factors and time to surgery in  patients with Parkinson’s Disease (PD) evaluated for deep brain stimulation…
  • 2026 International Congress

    The Impact of Delaying Subcutaneous Device-Aided Therapy for Patients with Advanced Parkinson’s Disease

    R. Wiggins, J. Lee, T. Boodhna, O. Yip, J. Homola, L. Pronk, R. van Den Puttelaar, J. Aldred (Charlotte, USA)

    Objective: This study aims to evaluate the clinical, humanistic, and societal impact of delayed SC therapy in patients with PD. Background: As Parkinson’s disease (PD)…
  • 2026 International Congress

    Bidirectional associations between seizures and parkinsonism: a retrospective case series

    Y. Chen, J. Fleisher, R. O'Dwyer (Chicago, USA)

    Objective: Within a single center, describe individuals with parkinsonism who develop seizures and vice versa based on epilepsy and movement disorders evaluation. Background: While neurodegeneration…
  • 2026 International Congress

    A Novel Clinical Protocol for Monitoring Therapeutic Outcomes in Camptocormia in Parkinson´s Disease

    L. Lundh, E. Franzén, S. Grigoriou, M. Söderholm, W. Duzynski, F. Strömqvist, B. Lindholm (Ängelholm, Sweden)

    Objective: To present a case study using a novel protocol evaluating postural, pain, and respiratory outcome in PD-related camptocormia before and after treatment. Background: Camptocormia…
  • 2026 International Congress

    Qihuang Needle Therapy for Motor Symptoms in Parkinson’s Disease: A Randomized Controlled Trial

    WQ. Peng, RH. Zhao, ZT. Huang, NB. Wang, ZH. Chen (Guangzhou, China)

    Objective: To evaluate the efficacy of Qihuang needle therapy for improving motor and non-motor symptoms in patients with Parkinson’s disease (PD). Background: Motor symptoms in…
  • 2026 International Congress

    Survival and Related Factors in Patients with Parkinson’s Disease : A Multicenter Prospective Cohort Study in China

    S. Song, L. Xiang, Y. Liu, H. Pan, Y. Wu, X. Li, F. Luo, C. Wang, L. Lei, L. Yao, Y. Zhao, Z. Liu, Q. Sun, J. Guo, B. Tang, I. Wu, L. Yin, X. Zhou, Q. Xu (Changsha, China)

    Objective: To estimate mortality, standardized mortality ratios (SMRs), causes of death, and survival-related risk factors in a large, multicenter Parkinson’s disease (PD) cohort from the…
  • 2026 International Congress

    In Vivo 18F-Florzolotau Tau PET Imaging in Parkinson’s Disease with and without Probable REM Sleep Behavior Disorder

    C. Xu, Y. Tang, J. Wang (Shanghai, China)

    Objective: To investigate the distribution and potential influence of tau pathology in Parkinson’s disease (PD) patients with and without prodromal REM sleep behavior disorder (pRBD),…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley